John Chiplin

John has many years of experience in life science companies and has sat on a number of LSE, NASDAQ, and ASX listed boards. He is Managing Director of Newstar Ventures, a healthcare investment and advisory firm, and contributes strong strategic and corporate finance skills to the Group. John is also Chairman of N4 Pharma plc and Biotherapy Services (as a representative of Foresight Group) and is a Director of Regeneus Limited (ASX).